Fak/Src signaling in human intestinal epithelial cell survival and anoikis:: Differentiation State-specific uncouplin with the P13-K/Akt-1 ang MEK/Erk pathways

被引:113
|
作者
Bouchard, Vtronique
Demers, Marie-Josee
Thibodeau, Sonya
Laquerre, Vincent
Fujita, Naoya
Tsuruo, Takashi
Beaulieu, Jean-Francois
Gauthier, Remy
Vezina, Anne
Villeneuve, Lisabeth
Vachon, Pierre H. [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada
[2] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan
[3] Univ Sherbrooke, Ctr Hosp, Themat Rech Physiopathol Digest Ctr, Rech Clin Etienne Lebel, Sherbrooke, PQ J1K 2R1, Canada
关键词
D O I
10.1002/jcp.21096
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human intestinal epithelial cell survival and anoikis are distinctively regulated according to the state of differentiation. In the present study, we analyzed the roles of focal adhesion kinase (Fak)/Src signaling to the P13-K/Akt- I and mitogen -activated protein kinase (MEK)/ extracellular regulated kinases (Erk) pathways, within the context of such differentiation -state distinctions. Anoikis was induced by inhibition of beta I integrins (antibody blocking), inhibition of Fak (pharmacologic inhibition or overexpression of dominant negative mutants), or by maintaining cells in suspension. Activation parameters of Fak, Src, Akt- 1, and Erk 1 /2 were analyzed. Activities of Src, Akt- 1, or Erk 1 /2 were also blocked by pharmacological inhibition or by overexpression of dominant-negative mutants. We report that: (1) the loss or inhibition of P I integrin binding activity causes anoikis and results in a down-activation of Fak, Src, Akt- 1, and Erk 1 /2 in both undifferentiated, and differentiated cells; (2) the inhibition of Fak likewise causes anoikis and a down-activation of Src, Akt- 1, and Erk 1 /2, regardless of the differentiation state; (3) Src, P]3-K/Akt- 1, and MEK/Erk contribute to the survival of differentiated cells, whereas MEK/ Erk does not play a role in the survival of undifferentiated ones; (4) the inhibition/loss of P I integrin binding and/or Fak activity results in a loss of Src engagement with Fak, regardless of the state of differentiation; and (5) Src contributes to the activation of both the P13-K/Akt- I and MEK/Erk pathways in undifferentiated cells, but does not influence P13-K/Akt- I in differentiated ones. Hence, Fak/Src signaling to the P13-K/Akt- I and MEK/Erk pathways undergoes a differentiation state-specific uncoupling which ultimately reflects upon the selective engagement of these same pathways in the mediation of intestinal epithelial cell survival.
引用
收藏
页码:717 / 728
页数:12
相关论文
共 5 条
  • [1] Intestinal Epithelial Cancer Cell Anoikis Resistance: EGFR-Mediated Sustained Activation of Src Overrides Fak-Dependent Signaling to MEK/Erk and/or PI3-K/Akt-1
    Demers, Marie-Josee
    Thibodeau, Sonya
    Noel, Dominique
    Fujita, Naoya
    Tsuruo, Takashi
    Gauthier, Remy
    Arguin, Melina
    Vachon, Pierre H.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 107 (04) : 639 - 654
  • [2] Human intestinal epithelial crypt cell survival and death:: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1. MEK/Erk, and p38 signaling pathways
    Harnois, C
    Demers, MJ
    Bouchard, V
    Vallée, K
    Gagné, D
    Fujita, N
    Tsuruo, T
    Vézina, A
    Beaulieu, JF
    Côté, A
    Vachon, PH
    JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 198 (02) : 209 - 222
  • [4] Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of P13K/AKT and MEK/ERK signaling pathways
    Li, Shun
    Chen, Xiangrong
    Mao, Lifang
    Zahid, Kashif Rafiq
    Wen, Jun
    Zhang, Liu
    Zhang, Maoying
    Duan, Junwei
    Duan, Jie
    Yin, Xiaohong
    Wang, Yuanchuan
    Zhao, Long
    Tang, Xiaoping
    Wang, Xiangyu
    Xu, Guozheng
    BRAIN RESEARCH, 2018, 1692 : 154 - 162
  • [5] 11-epi-Sinulariolide Acetate Reduces Cell Migration and Invasion of Human Hepatocellular Carcinoma by Reducing the Activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR Signaling Pathways
    Lin, Jen-Jie
    Su, Jui-Hsin
    Tsai, Chi-Chu
    Chen, Yi-Jen
    Liao, Ming-Hui
    Wu, Yu-Jen
    MARINE DRUGS, 2014, 12 (09) : 4783 - 4798